SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-22-000200
Filing Date
2022-11-09
Accepted
2022-11-09 07:07:18
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20220930.htm   iXBRL 10-Q 1783501
2 EX-10.1 brownsteincarrie-employmen.htm EX-10.1 120801
3 EX-10.2 voliotisdimitris-zentalisr.htm EX-10.2 92846
4 EX-10.3 bunkerkevin-aremploymentag.htm EX-10.3 121893
5 EX-31.1 zentalis10-qq32022ex311.htm EX-31.1 10989
6 EX-31.2 zentalis10-qq32022ex312.htm EX-31.2 11233
7 EX-32.1 zentalis10-qq32022ex321.htm EX-32.1 5696
8 EX-32.2 zentalis10-qq32022ex322.htm EX-32.2 5277
14 image_0.jpg GRAPHIC 137
15 zntl-20220930_g1.jpg GRAPHIC 170551
  Complete submission text file 0001725160-22-000200.txt   7120198

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20220930.xsd EX-101.SCH 33891
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20220930_cal.xml EX-101.CAL 70755
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20220930_def.xml EX-101.DEF 147171
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20220930_lab.xml EX-101.LAB 451290
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20220930_pre.xml EX-101.PRE 297302
66 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20220930_htm.xml XML 956043
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 221370629
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences